D
Lexaria Bioscience Corp. LEXX
$1.35 $0.032.27%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

11/30/2024 08/31/2024 05/31/2024 02/29/2024 11/30/2023
Net Income -23.75% -22.62% -174.32% 44.92% 4.84%
Total Depreciation and Amortization 61.29% 13.76% -3.11% -43.32% -51.35%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 21.97% -77.44% 5,252.56% -92.32% -59.55%
Change in Net Operating Assets -201.78% 128.18% 19,175.00% 99.72% 79.93%
Cash from Operations -44.10% -49.41% -104.34% 47.57% 27.13%
Capital Expenditure 42.79% -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 50.38% -20.91% 61.40% -42.50% 41.52%
Cash from Investing 45.69% -216.36% 61.40% -42.50% 41.52%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -- -100.00% 46.06% 89.78% --
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing -- -100.00% 46.06% 89.78% 1,594.99%
Foreign Exchange rate Adjustments -252.38% 275.00% 95.20% -668.18% --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 180.56% -152.19% 36.44% 356.93% 133.23%
Weiss Ratings